RT @pash22: This is unbelievable! The IVAN study was funded by UK govt, so why was it funded if the govt wasn’t going 2 act on the results?…
This is unbelievable! The IVAN study was funded by UK govt, so why was it funded if the govt wasn’t going 2 act on the results? Taxpayers’ ££ paid for that research via @OfficialNIHR which concluded that Avastin was equivalent to more expensive options @Cl
@felly500 @pash22 It’s from here https://t.co/FQHFNb5MbC
Bevacizumab (Avastin): a new way of doing business https://t.co/hjlMAzgKlY via @RCOphthPres
"Bevacizumab: a new way of doing business. Part 2" https://t.co/Hvp6CeCneI #ophthalmology #feedly
Now Online: Bevacizumab: a new way of doing business. Part 2. - Editorial on the recent Avastin ruling by former editor of Eye @AndrewLotery and RCOphth President, Mike Burdon (@RCOphthPres). #Ophthalmology #AMD https://t.co/Em6LVDResL https://t.co/HlQxFih
Ophthopedia Update: Bevacizumab: a new way of doing business. Part 2 https://t.co/7OxEVFfQNu #Ophthalmology #Eye #Ophthotwitter
Ophthopedia Update: Bevacizumab: a new way of doing business. Part 2 https://t.co/wMKfY1sz9E #Ophthalmology #Eye #Ophthotwitter